U.S. Consumer Finance Stock News

Dynatrace executive Stephen McMahon recently purchased a significant amount of NYSE:DT stock, according to a regulatory filing. The purchase comes shortly after the company highlighted its focus on artificial intelligence at a major technology conference. The move is being watched by investors as a potential signal of internal confidence at a current share price of $39.28. For investors tracking NYSE:DT, this insider buying lands at a time when the stock has seen mixed recent performance...

Vita Coco Company (COCO) has been in focus after its latest quarterly results, where revenue, EBITDA, and adjusted operating income exceeded analyst expectations, but full year guidance came in weaker than that of its peers. See our latest analysis for Vita Coco Company. Despite the softer full year guidance and the recent pullback, including a 1 month share price return of 12% decline and a 7 day share price return of 10.9% decline, Vita Coco still shows strong long term momentum with a 1...

Newmark Group (NMRK) is back in focus after releasing Q4 and full year 2025 results that showed higher revenue and net income year on year, alongside an upbeat management outlook for 2026. See our latest analysis for Newmark Group. The solid 2025 earnings and ongoing buyback activity are landing against a softer share price backdrop, with a 1 month share price return of 15.25% decline and a year to date share price return of 15.85% decline. At the same time, the 3 year total shareholder...

If you are wondering whether Boot Barn Holdings shares still offer value after a strong multi year run, it helps to break the story down into what the recent price action and fundamentals might be implying. The stock last closed at US$178.14, and while it is down 5.9% over the past week and 12.4% over the past month, the 1 year return of 64.0% and 3 year return of 139.1% set an important backdrop for any valuation check. Recent commentary around the company has focused on its position in the...

Nutex Health (NUTX) is back in focus after reporting full year 2025 results and unveiling a fresh share repurchase program, pairing weaker Q4 numbers with a new commitment to buying back stock. See our latest analysis for Nutex Health. The Q4 earnings miss and new buyback plan landed against a sharp reset in sentiment. A 90 day share price return of 50.14% decline and year to date share price return of 39.08% decline contrast with a 1 year total shareholder return of 102.15%, suggesting...

LandBridge (NYSE:LB) has entered the battery energy storage sector through agreements for 350 MW of new projects. The company has recently executed about 450 new easements and development agreements tied to its expanding infrastructure activities. These moves reflect a broadening of LandBridge's business beyond its traditional land and resource management focus. For investors watching NYSE:LB, the stock's recent run, with a 27.6% return over the past 30 days and 49.4% return year to date,...

Macro jitters hit Bio-Techne after weak healthcare jobs data Bio-Techne (TECH) came under pressure after a weak February employment report showed sizable job losses in healthcare, prompting investors to reassess spending risks for companies supplying research and diagnostic products. See our latest analysis for Bio-Techne. At a share price of US$53.89, Bio-Techne’s recent 1 month share price return of a 19.3% decline and 1 year total shareholder return of a 15.8% decline point to fading...

Alphabet (NasdaqGS:GOOGL) is facing its first wrongful death lawsuit linked to its Gemini AI chatbot. The claim alleges the chatbot contributed to a user's self-harm, raising questions about AI safety and responsibility. The case is drawing fresh attention to legal, ethical, and compliance risks for generative AI products. For you as an investor, this is a reminder that Alphabet is not just a search and advertising business. It is now deeply tied to generative AI through products like...

Atlanta Braves Holdings (BATR.K) is in focus after releasing its fourth quarter and full year 2025 results, alongside announcing BravesVision, a new in house multimedia platform that is set to handle local Braves telecasts starting in 2026. See our latest analysis for Atlanta Braves Holdings. The latest announcements around BravesVision and the 2025 results come after a period where the share price has gained 11.78% over 30 days and 13.17% over 90 days, while the 5 year total shareholder...

In early March 2026, Atmus Filtration Technologies was caught up in market jitters after Middle East tensions pushed crude oil prices higher, stoking fresh worries about inflation and interest rate cuts being pushed back. This external shock mainly reflected broader macro concerns rather than any direct change to Atmus’s filtration business, but it highlights how sentiment around monetary policy and economic conditions can still influence perceptions of the company’s earnings resilience and...

If you are wondering whether Lithia Motors' current share price reflects its true worth, you are not alone. This article is designed to help you unpack that question clearly. The stock last closed at US$259.65, with recent returns of a 7.1% decline over 7 days, a 24.6% decline over 30 days, a 21.9% decline year to date, and a 14.2% decline over 1 year, while the 3 year return is 7.9% and the 5 year return is a 32.2% decline. Recent share price moves have put more attention on how the market...

Cboe Global Markets recently reported record February 2026 trading activity across its proprietary index options and European equities platforms, coinciding with a spike in its VIX volatility benchmark amid geopolitical tensions. The combination of heightened volatility, strong earnings growth, and fresh institutional interest has highlighted Cboe’s leverage to both options volumes and off-exchange equity trading demand. With record index options volumes and strong earnings now in focus,...

Regulatory shift puts Capricor Therapeutics (CAPR) timelines under closer scrutiny The FDA’s move to tighten its expedited approval pathway directly affects Capricor Therapeutics (CAPR). This places more attention on how its Duchenne muscular dystrophy program and other rare disease candidates progress through upcoming clinical and regulatory checkpoints. See our latest analysis for Capricor Therapeutics. Capricor Therapeutics’ share price has moved to US$27.90 after a recent 1 day share...

If you are looking at Ally Financial and wondering whether the current share price offers solid value, you are not alone. This article is here to walk through what that price might actually represent. The stock closed at US$38.07, with returns of 3.5% decline over 7 days, 10.0% decline over 30 days, 16.8% decline year to date, 13.4% over 1 year, 63.7% over 3 years and 1.8% decline over 5 years, which may have shifted how some investors are thinking about both risk and opportunity. Recent...

Earnings and business model shift come into focus MicroVision (MVIS) has drawn fresh attention after reporting 2025 results with US$1.21 million in sales and a net loss of US$94.98 million, alongside guidance that points to projected 2026 revenue of US$10 million to US$15 million. At the same time, the company is reshaping itself around a software centric LiDAR model, integrating the Luminar and Scantinel acquisitions, consolidating operations into its Orlando manufacturing hub, and leaning...

Toll Brothers, NYSE:TOL, is launching new luxury home communities in Redondo Beach (CA), Parker (CO), Boulder City (NV), and Tomball (TX). The projects expand its presence across both coastal and inland premium housing markets in the U.S. The coordinated rollout signals a broadening of the company’s footprint into multiple fast growing regions. Toll Brothers enters this expansion phase with shares trading at $147.68 and a 1 year return of 36.3%. Over 3 years, the stock has delivered a gain...

A Vice President & Chief Accounting Officer at BWX Technologies recently sold company shares, extending a pattern of insider selling over the past year. The transactions come as geopolitical tensions in the Middle East increase investor interest and scrutiny of defense contractors such as NYSE:BWXT. Investors are weighing the insider activity against BWX Technologies' recent share performance and its role in the defense sector. BWX Technologies, trading under NYSE:BWXT, last closed at...

S&P Global (NYSE:SPGI) has launched its DataXchange and AmendX platforms to digitize private credit and syndicated loan workflows. The new tools aim to centralize data, streamline agency and lender processes, and support compliance across complex loan structures. Both platforms use AI driven categorization and standardized workflows to tackle operational bottlenecks in private markets. For you as an investor, the launch comes as S&P Global trades around $452.36 per share, with a 42.0%...

EC approval of Zynyz sets fresh context for Incyte’s stock story Incyte (INCY) just received European Commission approval for Zynyz, used with carboplatin and paclitaxel, as a first line treatment for advanced squamous cell carcinoma of the anal canal. This regulatory decision, grounded in Phase 3 POD1UM-303 data showing improved progression free survival versus chemotherapy alone, adds a second European indication for Zynyz and gives investors another clinical milestone to weigh. See our...

In February 2026, United Rentals Inc. and Procore Technologies announced a new partnership delivering their first telematics integration, allowing mutual customers to feed United Rentals’ equipment data directly into Procore’s Resource Management platform to improve visibility and equipment coordination across jobsites. This integration introduces AI-supported, centralized management of owned and rented equipment, labor, and materials, potentially tightening the connection between office...

International Money Express (IMXI) has wrapped up FY 2025 with fourth quarter revenue of US$147.4 million and basic EPS of US$0.30, alongside net income of US$8.9 million. These results help frame how investors interpret the year. The company’s quarterly revenue has moved from US$171.9 million and EPS of US$0.53 in Q3 2024 to US$147.4 million and EPS of US$0.30 in Q4 2025, with trailing twelve month net profit margins easing from 8.9% to 5.4%. The latest figures highlight the question of how...

In early March 2026, Quantum Computing Inc. reported fourth-quarter 2025 results showing sales of US$198,000, a much smaller net loss of US$1.56 million, and confirmed the opening of its Fab 1 photonic chip facility alongside the completed acquisitions of Luminar Semiconductor and NuCrypt. The company’s shift toward a vertically integrated photonics and quantum communications platform, backed by more than US$1.55 billion of fresh capital, is reshaping how investors assess its path from niche...

In early March 2026, Predactiv announced an integration with LiveRamp that lets clients convert offline PII into secure, privacy-compliant identifiers for activation across The Predactiv Data Platform, while LiveRamp separately launched new AI agent capabilities to automate campaign planning, execution, and measurement. Together, these moves deepen LiveRamp’s role as infrastructure for privacy-safe data monetization and AI-assisted marketing workflows across multiple partners and...

Coca-Cola FEMSA. de (NYSE:KOF) recently reported fourth quarter and full year 2025 earnings, with both sales and net income figures for the period giving investors fresh data on volumes, regional trends, and regulatory pressures. See our latest analysis for Coca-Cola FEMSA. de. The recent earnings release comes after a solid 12 months for investors, with a 1 year total shareholder return of 25.98% and a 5 year total shareholder return of 167.69%. This is even though the 7 day share price...